|
|
|
| Clinical observation of total resection of bladder tumor with transurethral fluoroscopy |
| ZHOU Rongsheng1 YU Quansheng2 ZANG Guanghui1 PANG Kun1 ZHOU Xiangju1 HE Houguang1 LIANG Qing1 HAN Conghui1▲ |
| 1.Department of Urology, Xuzhou Central Hospital Xuzhou Reproductive Institute of Central South University, Jiangsu Province, Xuzhou 221009, China; 2.Department of Urology, Shuyang County People's Hospital, Jiangsu Province, Shuyang 223600, China |
|
|
|
Abstract Objective To investigate the clinical method of transurethral resection of bladder tumor with cystoscopy in the treatment of bladder tumor. Methods From January 2014 to December 2015, 40 patients with bladder cancer who were treated at Xuzhou Central Hospital were observed. All the patients were treated with sacral obstruction anesthesia. 45 cases of tumor were removed, including 36 cases of tumor were single tumor, and the tumor diameter was 0.5~2 cm, which were located in the posterior wall of the bladder or the location of the neck. Firstly, the tumor size and location of the bladder were observed by fluorescent cystoscopy. Then the bladder wall full of bladder fat was cut by the plasma along the tumor proximal, along the tumor in full-thickness resection, the final resection of the tumor distal complete resection of the tumor and its basal bladder full-thickness pathology. Results 40 patients were successfully completed operation, and the operation time was 10-40 min, the mean time was (23.95±8.39) min. The intraoperative blood loss was very few, and there was no secondary bleeding after operation. 34 cases were postoperative tumor stage T1 and 6 cases were postoperative tumor stage T2. Patients were followed up 12-24 months after operation, the mean time was (14.89±1.97) months, no tumor case was recurred. Conclusion Transurethral resection of bladder tumor under cystoscopy can completely remove the tumor and tumor base, which can prevent the removal of the suspected bladder wall under fluorescence, and the surgery effect is exact.
|
|
|
|
|
|
[1] 李双辉，张志宏，徐勇，等.根治性经尿道膀胱肿瘤电切术加化疗治疗肌层浸润性膀胱癌的疗效分析[J].中华泌尿外科杂志，2012，33（3）：215-218.
[2] 那彦群.中国泌尿外科疾病诊断治疗指南手册：2014版[M].北京：人民卫生出版社，2014.
[3] 杨晓峰，王东文.经尿道膀胱肿瘤切除术手术方式的进展[J].中华腔镜泌尿外科杂志2014，8（3）：60-64.
[4] 赫捷, 陈万青. 2012中国肿瘤登记年报[M].北京：军事医学科学出版社，2012.
[5] Dobruch J，Daneshmand S，Fisch M，et al. Gender and bladder cancer：a collaborative review of etiology，biology，and outcomes [J]. Eur Urol，2016，69（2）：300-310.
[6] Chavan S，Bray F，Lortet TJ，et al. International variations in bladder cancer incidence and mortality [J]. Eur Urol，2014，66（1）：59-73.
[7] Babjuk M，Burger M，Zigeuner R，et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder：update 2013 [J]. Eur Urol，2008，54（2）：639-653.
[8] 刘杰昊，杨晓峰，王玮，等.人膀胱癌BIU-87细胞裸鼠皮下移植瘤模型的建立[J].国际泌尿系统杂志，2014，34（4）：465-468.
[9] Li HT，Duymich CE，Weisenberger DJ，et al. Genetic and epigenetic alterations in bladder cancer [J]. Int Neurourol J，2016，20（Suppl 2）：S84-S94.
[10] Babjuk M，Oosterlinck W，Sylvester R，et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder，the 2011 update [J]. Actas Urol Esp，2012，36（7）：389-402.
[11] Ieda T，Muto S，Shimizu F，et al. Development and validation of a novel recurrence risk stratification for initial non-muscle invasive bladder cancer in Asia [J]. EBio Med，2016，12（C）：98-104.
[12] Eifler JB，Scarpato KR，Clark PE. Management of noninvasive bladder cancers [J]. Curr Opin Oncol，2015，27（3）：185-190.
[13] Joudi FN，Konety BR. Fluorescence cystoscopy and bladder surveillance [J]. Curr Opin Urol，2004，14（5）：265-270.
[14] 李伟，张开颜，陈斌，等.窄带显像膀胱镜引导下经尿道膀胱肿瘤电切术降低膀胱肿瘤术后复发率[J].中国内镜杂志，2014，20（5）：531-535.
[15] Zaak D，Karl A，Stepp H，et al. Fluorescence cystoscopy at bladder cancer：present trials [J]. Urologe A，2007，46（11）：1519-1527.
[16] 王鹏，叶锦，张尧，等.荧光膀胱镜在血尿诊治中的应用评价（附58例报告）[J].中国美容医学，2012，21（z2）：101-102.
[17] 李海元，花晨朝.新型内镜成像技术在膀胱癌诊断中的应用进展[J].肿瘤防治研究，2016，43（5）：418-421.
[18] Jeon SS，Kang I，Hong J H，et al. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms [J]. J Endourol，2001，15（7）：753-759.
[19] Grimbergen MC，Swol CF，Jonges TG，et al. Reduced spe-cificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy [J]. Eur Urol，2003，44（1）：51-56.
[20] 马天加，王文振，姜兆群，等.NBI辅助钬激光与TURBt治疗非肌层浸润性膀胱尿路上皮癌的前瞻性随机对照研究[J].中华医学杂志，2015，95（37）：3032-3035.
[21] Tauber S，Schneede P，Liedl B，et al. Fluorescence cytology of the urinary bladder [J]. Urology，2003，61（5）：1067-1071.
[22] 郭和清，周高标，朱晓应，等. 5-ALA荧光膀胱镜的应用对非肌层浸润性膀胱癌早期复发率的影响[J].临床泌尿外科杂志，2011，26（6）：422-424.
[23] 郁华亮，杨勇，李建业，等. 经尿道2 μm激光膀胱部分切除术与经尿道膀胱肿瘤电切术治疗T1G3膀胱癌的疗效比较[J].解放军医学院学报，2015，36（3）：251-254.
[24] 贺大林，吴开杰，范晋海，等.肌层非浸润型膀胱肿瘤激光治疗的现状与展望[J].现代泌尿外科杂志，2015，20（6）：373-375. |
|
|
|
